T2DM related to factors such as insulin resistance, high oxLDL, systemic low-grade inflammation, or hepatosteatosis, stimulates CD36 expression in monocytes and macrophages localized in adipose tissue, the liver, and arteries leading to elevated plasma sCD36. This evidence concerns the gene CD36 and type 2 diabetes mellitus.